Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-08-02

Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cells Injection for Ocular Corneal Burn [Phase 1, Phase 2]

View source ↗

Summary

This document provides a clinical trial update for a Phase 1/2 study evaluating injections of umbilical cord mesenchymal stem cells to treat ocular corneal burn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical cord mesenchymal stem cells injection

Snippet

Sponsor: Guangzhou Saliai Stem Cell Science and Technology Co. Ltd. | Conditions: Ocular Corneal Burn | Phase 1, Phase 2 | Status: UNKNOWN